Inseal Medical Ltd.
Large-bore access closure devices for the interventionalist
This article was originally published in Start Up
New minimally invasive interventions for structural heart disease use ever larger devices, creating challenges for transfemoral access site management. While the current state of the art is trying to transform surgical practices into interventional ones, Inseal Medical has a large-bore vascular access closure device that works the way interventional cardiologists do.
You may also be interested in...
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.